SEMA3E and asthma: Furthermore, tissue resistance (G) demonstrated a significant increase in the Sema3E KO type-2 high asthma model that peaked at the 12 mg/ml (p < 0.001) and dose 50 mg/ml methacholine dose (p < 0.05) compared with the WT counterpart (Fig 1I).